ACADIAN ASSET MANAGEMENT LLC - UROGEN PHARMA LTD ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$63
-14.9%
4,563
-36.5%
0.00%
Q2 2023$74
+76.2%
7,187
+57.5%
0.00%
Q1 2023$42
-100.0%
4,563
-14.1%
0.00%
-100.0%
Q1 2018$264,000
-70.1%
5,315
-77.6%
0.00%
-75.0%
Q4 2017$884,000
+14.1%
23,740
-3.5%
0.00%
+33.3%
Q3 2017$775,00024,5930.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders